Immunotherapy has revolutionized the field of oncology, offering hope in the face of previously untreatable malignancies. This article aims to elucidate the principles of immunotherapy, its applications, and potential side effects.
Immunotherapy harnesses the power of the body's immune system to fight cancer. It works by either stimulating the immune system to attack cancer cells or providing it with synthetic immune system proteins. Key strategies include checkpoint inhibitors, CAR T-cell therapy, and cancer vaccines.
The scope of immunotherapy extends across various malignancies. It has proven effective in treating melanoma, lung, kidney, bladder, head and neck cancers, and certain types of lymphoma. Research is ongoing to expand its applicability to other cancer types.
Checkpoint inhibitors work by blocking immune checkpoints, proteins that prevent immune cells from attacking normal cells. By inhibiting these checkpoints, these drugs allow the immune system to recognize and attack cancer cells. Examples include pembrolizumab and nivolumab.
Chimeric Antigen Receptor (CAR) T-cell therapy involves modifying a patient's T cells to express receptors that bind to specific proteins on cancer cells, enhancing their ability to seek out and destroy the malignancy. This therapy has shown promising results in treating certain types of leukemia and lymphoma.
Cancer vaccines, like the HPV vaccine, aim to prevent cancer by stimulating the immune system to attack specific viruses that cause cancer. Therapeutic cancer vaccines, on the other hand, are designed to treat existing cancers by triggering the immune system to recognize and attack cancer cells.
While immunotherapy offers significant benefits, it also carries potential side effects, often resembling autoimmune reactions, as the immune system becomes more active. These can range from mild fatigue and fever to severe lung inflammation and endocrine disorders.
Immunotherapy represents a significant breakthrough in the treatment of many cancers. By understanding its principles, applications, and potential side effects, physicians can better guide their patients through the complexities of cancer treatment.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation